Is a high hematocrit value an independent risk factor for adverse outcome after coronary artery bypass grafting? [1] (multiple letters)

Journal of Thoracic and Cardiovascular Surgery

Volumn 118, Issue 4, 1999, Pages 765-766

  Graham, A ^a   O'Kane, H ^a   Spiess, B D ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; PLACEBO; TRANEXAMIC ACID;

CORONARY ARTERY BYPASS GRAFT; HEART INFARCTION; HEMATOCRIT; HUMAN; HYPERCOAGULABILITY; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; Q WAVE; RISK FACTOR;

EID: 0032824465     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(99)70034-6     Document Type: Letter

References (8)

1. BD Spiess C Ley SC Body LC Siegel EP Stover R Maddi Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting: the Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group J Thorac Cardiovasc Surg 116 1998 460 467
2. EL Alderman JH Levy JB Rich M Nili B Vidne H Schaff Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial J Thorac Cardiovasc Surg 116 1998 716 730
3. JH Levy R Pifarré HV Schaff JC Horrow R Albus B Spiess A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting [see comments] Circulation 92 1995 2236 2244
4. DM Cosgrove B Heric BW Lytle PC Taylor R Novoa LA Golding Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study [see comments] Ann Thorac Surg 4 1992 1031 1036 discussion 1036-8
5. J van der Meer HL Hillege CA Ascoop PH Dunselman BJ Mulder GV van Ommen Aprotinin in aortocoronary bypass surgery: Increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study Thromb Haemost 75 1996 1 3
6. M Lass A Welz M Kochs G Mayer M Schwandt A Hannekum Aprotinin in elective primary bypass surgery: graft patency and clinical efficacy Eur J Cardiothorac Surg 9 1995 206 210
7. A Kalangos G Tayyareci R Pretre P Di Dio O Sezerman Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization Eur J Cardiothorac Surg 8 1994 651 656
8. P Feindt U Seyfert I Volkmer H Huwer G Kalweit E Gams Is there a phase of hypercoagulability when aprotinin is used in cardiac surgery? Eur J Cardiothorac Surg 8 1994 308 313 discussion 313-4.